API plant sourcing made simple with IPP’s global inventory and expertise

IPP offers turnkey API plant solutions, including land, equipment, and regulatory documentation.

For manufacturers looking to buy or repurpose an API plant, International Process Plants (IPP) offers a rare advantage: complete, ready-to-operate facilities with equipment, documentation, and infrastructure already in place. From small-scale batch plants to large-scale multipurpose facilities, IPP is the go-to global partner for sourcing pharmaceutical-grade operations.

What makes IPP unique is its unmatched inventory and deep regulatory experience. The company owns more than 20 complete manufacturing sites, including former API facilities from top pharmaceutical producers. These plants often come with validated equipment, cleanroom infrastructure, HVAC systems, and water-for-injection setups—enabling companies to resume production quickly and cost-effectively.

“Speed matters in the pharma world,” said Ron Gale, Vice President at IPP. “When clients come to us for an API plant, they’re often trying to fast-track a project or meet a regulatory window. Our role is to reduce lead times from years to months—and we’ve done that again and again.”

Unlike traditional greenfield construction, acquiring a pre-existing facility can slash costs by 60% and reduce startup timelines by up to 90%. And because many of IPP’s API plants have been GMP-compliant, restarting production often involves minimal upgrades or permitting delays.

Beyond the real estate and equipment, IPP provides regulatory documentation packages, historical validation data, and support for environmental permitting. Their in-house decommissioning and sustainability program ensures a smooth transition with 95% of materials responsibly recycled.

📌 Recently, IPP leased a U.S.-based fermentation and API plant to Nuol Green Chemistry, drawing coverage from outlets like SOCMA and ROI-NJ. That plant is now being used to produce green solvents at scale.

• Rapid access to GMP-compliant facilities
• Full documentation and validation packages available
• Dramatically reduced capital and timeline requirements
• Global inventory in the U.S., Europe, and Asia
• Support for permitting, logistics, and customization

IPP’s ISN RAVS Plus certification underscores its commitment to safety and compliance—a crucial consideration for buyers in the API and pharmaceutical sector.

📎 View available API plants

📎 IPP case study: Reviving a former Novartis site

📎 Contact IPP’s pharma specialists

What does API plant mean?

An API plant is a pharmaceutical manufacturing facility that produces Active Pharmaceutical Ingredients—chemical compounds that are the core of drug formulations.

Can IPP provide turnkey API plant solutions?

Yes. IPP offers fully equipped facilities, including land, validated systems, and regulatory support, ready for restart or repurposing.

Are these plants GMP-certified?

Many of IPP’s API plants were previously operated under GMP compliance. We provide documentation to help buyers confirm requirements.

How fast can a repurposed API plant be operational?

Depending on local regulations, production can resume in a matter of months—up to 90% faster than greenfield builds.

🔗 More equipment FAQs